Skip to main content
. 2024 Jul 17;56:101029. doi: 10.1016/j.neo.2024.101029

Fig. 4.

Fig 4

Kaplan-Meier curves of PFS and OS containing log-rank test. (a), (b) advanced first-line, second-line and third-or-post-line patients; (c), (d) Trastuzumab-sensitive and Trastuzumab-insensitive patients. mPFS-median progression free survival, mOS- median overall survival.